Clinical Trials Browser

Recruiting × INDUSTRY × HER2-positive Advanced Breast Cancer × Clear all

NCT07047365 2026-06-03

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Phase 3 Recruiting

HER2-positive Advanced Breast Cancer